Erratum: Broccoli: A unique vegetable that protects Mammalian hearts through the redox cycling of the thioredoxin superfamily (Journal of Agricultural and Food Chemistry (2008) 56: 2 (609-617) DOI: 10.1021/jf0728146);Broccoli: A unique vegetable that protects mammalian hearts through the redox cycling of the thioredoxin superfamily

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 2, 2008, Pages 609-617

  Mukherjee, Subhendu ^a   Gangopadhyay, Hiranmoy ^a,b   Das, Dipak K ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b JADAVPUR UNIVERSITY   (India)

Author keywords

Broccoli; Cardioprotection; Glutaredoxin; Heart; Ischemia reperfusion; Nrf2; Peroxiredoxin; Redox signaling; Survival signaling; Thioredoxin

Indexed keywords

ANIMALIA; BRASSICA OLERACEA VAR. ITALICA; MAMMALIA; RATTUS;

EID: 38949114867     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf3008585     Document Type: Erratum

References (47)

1. Matusheski, N. V.; Swamp, R.; Juvik, J. A.; Mithen, R.; Bennett, M.; Jeffery, E. H. Epithiospecifier protein from broccoli (Brassica oleracea L. ssp italica) inhibits formation of the anticancer agent sulforaphane. J. Agric. Food Chem. 2006, 54, 2069-2076.
2. Finley, J. W. Reduction of cancer risk by consumption of selenium-enriched plants: enrichment of broccoli with selenium increases the anticarcinogenic properties of broccoli. J. Med. Food 2003, 6, 19-26.
3. Perocco, P.; Bronzetti, G.; Canistro, D.; Valgimigli, L.; Sapone, A.; Affatato, A.; Pedulli, G. F.; Pozzetti, L.; Broccoli, M.; Iori, R.; Barillari, J.; Sblendorio, V.; Legator, M. S.; Paolini, M.; Abdel-Rahman, S. Z. Glucoraphanin, the bioprecursor of the widely extolled chemopreventive agent sulforaphane found in broccoli, induces phase-1 xenobiotic metabol;izing enzymes and increases free radical generation in rat fiver. Mutat. Res. 2006, 595, 125-136.
4. Finley, J. W.; Sigrid-Keck, A.; Robbins, R. J.; Hintze, K. J. Selenium enrichment of broccoli: interaction between selenium and secondary plant compounds. J. Nutr. 2005, 135, 1236-1239.
5. Nestle, M. Broccoli sprouts as inducers of carcinogen-detoxifying enzyme systems: clinical, dietary, and policy implications. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 11149-11151.
6. Tanito, M.; Masutani, H.; Kim, Y. C.; Nishikawa, M.; Ohira, A.; Yodoi, J. Sulforaphane induces thioredoxin through the antioxidant-response element and attenuates retinal light damage in mice. Invest. Opthal. Vis. Sci. 2005, 46, 979-987.
7. Murashima, M.; Watanabe, S.; Zhuo, X. G.; Uehara, M.; Kurashige, A. Phase I study of multiple biomarkers for metabolism and oxidative stress after one-week intake of broccoli sprouts. Biofactors 2004, 22, 271-275.
8. Yochum, L.; Kushi, L. H.; Meyer, K.; Folsorn, A. R. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am. J. Epidemiol. 1999, 149, 943-949.
9. Liang, H; Yuan, Q. P.; Dong, H. R.; Liu, Y. M. Determination of sulforaphane in broccoli and cabbage by high performance liquid chromatography. J. Food Sci. 2006, 19, 473-476.
10. Finlay, J.; Matthys, L.; Shuler, T.; Korynta. Selenium content of foods purchased in North Dakota. Nutr. Res. (N.Y.) 1996, 16, 723-728.
11. Engelman, D. T.; Watanabe, M.; Engelman, R. M.; Rousou, J. A.; Kisin, E.; Kagan, V. E.; Maulik, N.; Das, D. K. Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovasc. Res. 1995, 29, 133-140.
12. Ray, P. S.; Martin, J. L.; Swanson, E. A.; Otani, H.; Dillmann, W. H.; Das, D. K. Transgene overexpression of alpha B Crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion. FASEB J. 2001, 15, 393-402.
13. Sato, M.; Cordis, G. A.; Maulik, N.; Das, D. K. SAPKs regulation of ischemic preconditioning. Am. J. Physiol. 2000, 279, H901-H907.
14. Green, D. R.; Reed, J. C. Mitochondria and apoptosis. Science 1998, 281, 1309-1312.
15. Zhang, Y.; Talalay, P.; Cho, C. G.; Posner, G. H. A major inducer of anti-carcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 2399-2403.
16. Tanito, M.; Masutani, H.; Kim, Y. C.; Nishikawa, M.; Obira, A.; Yodoi, J. Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice. Invest. Opthalmol. Vis. Sci. 2005, 46, 979-987.
17. Malik, G.; Gorvanov, N.; Das, S.; Otani, H.; Das, D. K. Ischemic preconditioning triggers nuclear translocation of thioredoxin and its interaction with ref-1 potentiating a survival signal throuough pi-3-kinase-akt pathway. Antioxid. Redox Signal. 2006, 8, 2101-2109.
18. Das, D. K. Thioredoxin regulation of ischemic preconditioning. Antioxid. Redox Signal. 2004, 6, 405-412.
19. Turoczi, T.; Chang, V. W.; Engelman, R. M.; Maulik, N.; Ho, Y. S.; Das, D. K. Thioredoxin redox signaling in the ischemic heart. An insight with transgenic mice overexpressing Trx-1. J. Mol. Cell. Cardiol.
20. Holmgren, E.; Bjrnstedt, M. Thioredoxin and thioredoxin reductase. Methods Enzymol. 1995, 252, 199-208.
21. Hayashi, T.; Ueno, Y.; Okamoto, T. Oxido reductive regulation of nuclear factor kappa B: involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 1993, 268, 11380-11388.
22. Miyamoto, M.; Kishimoto, C.; Shioji, K.; Lee, J. D.; Shimizu, H.; Ueda, T.; Yodoi, J. Cutaneous arteriolar thioredoxin expression in patients with heart failure. Circ. J. 2003, 67, 116-118.
23. Nakamura, H.; Vaage, J.; Valen, G.; Padilla, C. A.; Bjornstedt, M.; Holmgren, A. Measurements of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery. Free Radical Biol. Med. 1998, 24, 1176-1186.
24. Jekell, A.; Hossain, A.; Alehagen, U.; Dahlstrom, U.; Rosen, A. Elevated circulating levels of thioredoxin and stress in chronic heart failure. Eur. J. Heart Failure 2004, 6, 883-890.
25. Miyamoto, M.; Kishimoto, C.; Shioji, K.; Lee, J. D.; Shimizu, H.; Ueda, T.; Yodoi, J. Cutaneous arteriolar thioredoxin expression in patients with heart failure. Circ. J. 2003, 67, 116-118.
26. Nimata, M.; Kishimito, C.; Shioji, K.; Ishizaki, K.; Kitaguchi, S.; Hashimoto, T.; Nagata, N.; Kawai, C. Upregulation of redox-regulating protein, thiordoxin, in endomyocardial biopsy samples of patients with myocarditis and cardiomyopathies. Mol. Cell. Biochem. 2003, 248, 193-196.
27. Mustacich, D.; Powis, G. Thioredoxin reductase. Biochem. J. 2000, 346, 1-8.
28. Daniels, L. A. Selenium metabolism and bioavailability. Biol. Trace Elem. Res. 1996, 54, 165-199.
29. Bjornstedt, M.; Odlander, B.; Kuprin, S.; Claesson, H. E.; Holmgren, A. Selenite incubated with NADPH and mammalian thioredoxin reductase yields selenide, which inhibits lipoxygenase and changes the electron spin resonance spectrum of the active site iron. Biochemistry 1996, 35, 8511-8616.
30. Mustacich, D.; Powis, G. Thioredoxin reductase. Biochem. J. 2000, 346, 1-8.
31. Miller, S.; Walker, S. W.; Arthur, J. R.; Nicol, F.; Pickard, K.; Lewin, M. H.; Howie, A. F.; Beckett, G. J. Selenite protects human endothelial cells from oxidative damage and induces thioredoxin reductase. Clin. Sci. 2001, 100, 543-550.
32. Beer, S. M.; Taylor, E. R.; Brown, S. E.; Dahm, C. C.; Costa, N. J.; Runswick, M. J.; et al. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant defence. J. Biol. Chem. 2004, 279, 47939-47951.
33. Holmgren, A. Thioredoxin and glutaredoxin syatems. J. Biol. Chem. 1989, 264, 13963-13966.
34. Johansson, C.; Lillig, C. H.; Holmgren, A. Human mitochondrial glutartedoxin reduces s-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. J. Biol. Chem. 2004, 279, 7537-7543.
35. Lillig, C. H.; Berndt, C.; Vergnolle, O.; Lonn, M. E.; Hudemann, C.; Bill, E.; et al. Characterization of human glutaredoxin 2 as iron-sulfur protein: a possible role as redox sensor. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 8168-8173.
36. Aslund, F.; Berndt, K. D.; Holmgren, A. Redox potentials of glutaredoxins and other thiol-disulfide oxidoreductases of the thioredoxin superfamily determined by direct protein-protein redox equilibria. J. Biol. Chem. 1997, 272, 30780-30786.
37. Johansson, C.; Lillig, C. H.; Holmgren, A. Human mitochondrial glutartedoxin reduces s-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. J. Biol. Chem. 2004, 279, 7537-7543.
38. Gautam, M.; Nagy, M.; Ho, Y.-S.; Maulik, N.; Das, D. K. Role of glutaredoxin-1 in cardioprotection: an insight with glrx1 transgenic and knockout animals. J. Mol. Cell. Cardiol. 2007 (in press).
39. Nagy, N.; Malik, G.; Fisher, A. B.; Das, D. K. Targeted disruption of peroxiredoxin 6 gene renders the heart vulnerable to ischemia-reperfusion injury. Am. J. Physiol. 2006, 291, H2636-H2640.
40. Zhang, D. D.; Hannink, M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cel. Biol. 2003, 23, 8137-8151.
41. Hong, F.; Freeman, M. L.; Liebler, D. C. Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Chem. Res. Toxicol. 2005, 18, 1917-1926.
42. Katoh, Y.; Lida, K.; Kang, M. I.; Kobayashi, A.; Mizukami, M.; Tong, K. I.; McMahon, M.; Hayes, J. D.; Itoh, K.; Yamamoto, M. Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome. Arch. Biochem. Biophys. 2005, 433, 342-350.
43. Ejima, K.; Layne, M. D.; Carvajal, I. M.; Nanri, H.; Ith, B.; Yet, S. F.; Perrella, M. A. Modulation of the thioredoxin system during inflammatory responses and its effect on heme oxygenase-1 expression. Antioxid. Redox Signal. 2002, 4, 569-575.
44. Das, D. K.; Maulik, N. Conversion of death signal into survival signal by redox signaling. Biochemistry 2004, 69, 10-17.
45. Gurusamy, N.; Malik, G.; Gorbunov, N. V.; Das, D. K. Redox activation of Ref-1 potentiates cell survival following myocardial ischemia reperfusion injury. Free Radical Biol. Med. 2007, 43, 397-407.
46. Schlessinger, J. New roles for Src kinases in control of cell survival and angiogenesis. Cell 2000, 100, 293-296.
47. Hattori, R.; Otani, H.; Uchiyama, T.; Imamura, H.; Cui, J.; Maulik, N.; Cordis, G. A.; Zhu, L.; Das, D. K. Src tyrosine kinase is the trigger but not the mediator of ischemic preconditioning. Am. J. Physiol. 2001, 281, H1066-H1074.